BiomX Acquires Majority Stake in DFSL Security Subsidiary

BiomX ( (PHGE) ) has provided an announcement.

On April 13, 2026, BiomX exercised an exclusive option and closed a Stock Purchase & Assignment Agreement with Mandragola Ltd. to acquire 100% of Mandragola’s holdings in DR. Frucht Systems Ltd., giving BiomX control of 60% of DFSL’s equity and making it a majority-owned operating subsidiary. The consideration package combines $750,000 in cash, a $3 million unsecured convertible note, common shares and warrants subject to shareholder approval, and a revenue-based bonus tied to DFSL achieving at least $25 million in annual sales from 2027.

DFSL’s LADAR-based detection systems, which use laser sensing and proprietary AI algorithms to reduce false alarms and track aerial and ground threats in real time, are intended to complement BiomX’s recently acquired Zorronet AI command-and-control platform and strengthen its position in AI-enabled security and defense solutions. The deal, conducted as a private offering under U.S. securities rules and contingent on Israeli regulatory and NYSE American shareholder approvals for certain issuances, signals BiomX’s accelerated push into defense, critical infrastructure, and first-response markets, supported by a planned Mandragola credit line to fund DFSL’s growth and debt obligations.

The most recent analyst rating on (PHGE) stock is a Buy with a $26.00 price target. To see the full list of analyst forecasts on BiomX stock, see the PHGE Stock Forecast page.

Spark’s Take on PHGE Stock

According to Spark, TipRanks’ AI Analyst, PHGE is a Neutral.

The score is held down primarily by weak financial performance (no revenue, ongoing cash burn, and negative equity) and a bearish technical setup (below key moving averages with negative MACD). Offsetting factors include cautiously constructive earnings-call progress on the pipeline and several strategic/financing corporate actions, but these are tempered by regulatory/clinical and listing/going-concern risks.

To see Spark’s full report on PHGE stock, click here.

More about BiomX

BiomX Inc., listed on the NYSE American under the ticker PHGE, is expanding from its origins into the defense and security technology sector, focusing on AI-enabled systems that integrate detection, analysis, and response. Its portfolio now includes the Zorronet AI command-and-control platform and, through acquisitions, advanced sensing technologies aimed at defense, critical infrastructure, and first-response markets.

DFSL, now a majority-owned subsidiary of BiomX, is an Israeli defense engineering company that develops proprietary LADAR-based detection systems for perimeter security, critical infrastructure protection, counter-UAS operations, and wide-area surveillance. Founded in 1995 and backed by government innovation programs, DFSL’s systems are deployed in mission-critical environments, where they are valued for high accuracy and low false-alarm rates.

Average Trading Volume: 1,044,144

Technical Sentiment Signal: Sell

Current Market Cap: $18.91M

For an in-depth examination of PHGE stock, go to TipRanks’ Overview page.